Senators: FDA Should Investigate Inaccuracies in Oximeter Blood Oxygen Readings Among Persons of Color

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Senators: FDA Should Investigate Inaccuracies in Oximeter Blood Oxygen Readings Among Persons of Color

Oximeter Sales Have Soared During COVID-19 Pandemic; Possibility of Racial Bias ‘Long Acknowledged’

Dennis Tosh

February 11, 2021 at 01:52 PM EST

Three senators have urged the FDA to review the accuracy of pulse oximeters across racially diverse groups in the wake of multiple studies showing that the devices — used to monitor blood oxygen levels — are providing misleading readings among patients of color. In a letter to Acting Commissioner of Food and Drugs Dr. Janet Woodcock, Sens. Elizabeth Warren, D-Mass., Cory Book... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Senators: FDA Should Investigate Inaccuracies in Oximeter Blood Oxygen Readings Among Persons of Color

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT